JASVINDER SINGH to Cost-Benefit Analysis
This is a "connection" page, showing publications JASVINDER SINGH has written about Cost-Benefit Analysis.
Connection Strength
0.128
-
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. Arthritis Res Ther. 2015 May 12; 17:120.
Score: 0.092
-
OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. J Rheumatol. 2011 Aug; 38(8):1728-34.
Score: 0.018
-
Biologicals for rheumatoid arthritis. BMJ. 2011 Jul 28; 343:d4027.
Score: 0.018